Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl

Journal of Neural Transmission

Volumn 112, Issue 11, 2005, Pages 1433-1445

  Jenei, V ^a   Zor, K ^a   Magyar, K ^b   Jakus, J ^a  

^a CHEMICAL RESEARCH CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Cell adhesion; Cytoskeleton; R ( ) deprenyl

Indexed keywords

CYTOCHROME P450 INHIBITOR; DEPRENYL N OXIDE; MONOAMINE OXIDASE B INHIBITOR; PROADIFEN; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DRUG ACTIVITY; DRUG EFFECT; EMBRYO; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CYTOCHROME P-450 ENZYME SYSTEM; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MICE; MONOAMINE OXIDASE INHIBITORS; NEURONS; NEUROPROTECTIVE AGENTS; NIH 3T3 CELLS; PC12 CELLS; PROADIFEN; RATS; SELEGILINE;

EID: 27144488651     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0295-3     Document Type: Article

References (54)

1. S Abu-Raya R Tabakman E Blaugrund V Trembovler P Lazarovici 2002 Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells. Eur J Pharmacol 434 109 116
2. H Braak E Braak 2000 Pathoanatomy of Parkinson's disease. J Neurol 247 II/3 II/10
3. MC Carrillo S Kanai M Nokubo K Kitani 1991 (-) Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48 517 521
4. P Coleman H Federoff R Kurlan 2004 A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 63 1155 1162
5. A Falsaperla PA Monici Preti C Oliani 1990 Selegiline versus oxiracetam in patients with Alzheimer-type dementia. Clin Ther 12 376 384
6. V Filip E Kolibas 1999 Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group. J Psychiatry Neurosci 24 234 243
7. CC Garner RG Zhai D Gundelfinger NE Ziv 2002 Molecular mechanisms of CNS synaptogenesis. Trends Neurosci 25 243 250
8. EA Grace J Busciglio 2003 Aberrant activation of focal adhesion proteins mediates fibrillar amyloid beta-induced neuronal dystrophy. J Neurosci 23 493 502
9. M Hamada-Kanazawa K Ishikawa K Nomoto T Uozumi Y Kawai M Narahara M Miyake 2004 Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett 560 192 198
10. GU Höglinger P Rizk MP Muriel C Duyckaerts WH Oertel I Caille EC Hirsch 2004 Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat Neurosci 7 726 735
11. K Jin AL Peel XO Mao L Xie BA Cottrell DC Henshall DA Greenberg 2004 Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101 343 347
12. E Junn MM Mouradian 2002 Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine. Neurosci Lett 320 146 150
13. M Katagi M Tatsuno A Miki M Nishikawa K Nakajima H Tsuchihashi 2001 Simultaneous determination of selegiline N-oxide, a new indicator for selegiline administration, and other metabolites in urine by high-performance liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl 759 125 133
14. M Katagi M Tatsuno H Tsutsumi A Miki T Kamata H Nishioka K Nakajima M Nishikawa H Tsuchihashi 2002 Urinary excretion of selegiline-N-oxide, a new indicator for selegiline administration in man. Xenobiotica 32 823 831
15. D Kiryushko T Kofoed G Skladchikova A Holm V Berezin E Bock 2003 A synthetic peptide ligand of neural cell adhesion molecule, (NCAM), C3d, promotes neuritogenesis and synaptogenesis and modulates presynaptic function in primary cultures of rat hippocampal neurons. J Biol Chem 278 12325 12334
16. J Knoll 1993 The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. J Neural Transm [Suppl] 40 69 91
17. J Knoll Z Ecseri K Kelemen J Nivel B Knoll 1965 Phenylisopropylmethyl- propinylamine (E-250), a new spectrum psychic energizer. Arch Int Pharmacodyn Ther 155 154 164
18. J Knoll K Magyar 1972 Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5 393 408
19. E Koutsilieri JF O'Callaghan TS Chen P Riederer WD Rausch 1994 Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neurons. Eur J Pharmacol 269 R3 R4
20. I Laplante R Beliveau J Paquin 2004 RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells. J Neurobiol 60 289 307
21. SJ Lee K Drabik NJ Van Wagoner S Lee C Choi Y Dong EN Benveniste 2000 ICAM-1-induced expression of proinflammatory cytokines in astrocytes: involvement of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways. J Immunol 165 4658 4666
22. K Magyar B Szende 2004 (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and antiapoptotic properties. Neurotoxicol 25 233 242
23. K Magyar B Szende J Lengyel K Tekes 1996 The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (-)-deprenyl research. J Neural Transm [Suppl] 48 29 43
24. K Magyar M Pálfi T Tábi H Kalász B Szende Szöko É 2004 Pharmacological aspects of (-)-deprenyl. Curr Med Chem 11 2017 2031
25. M Mikkonen H Soininen T Tapiola I Alafuzoff R Miettinen 1999 Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formation. Eur J Neurosci 11 1754 1764
26. RB Postuma W He J Nunan K Beyreuther CL Masters CJ Barrow DH Small 2000 Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. J Neurochem 74 1122 1130
27. F Qin J Shite W Mao CS Liang 2003 Selegiline attenuates cardiac oxidative stress and apoptosis in heart failure: association with improvement of cardiac function. Eur J Pharmacol 461 149 158
28. EE Sander JP Klooster S van Delft RA van Kammen JG Collard 1999 Rac downregulates Rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behaviour. J Cell Biol 147 1009 1021
29. K Schlett A Czirók K Tárnok T Vicsek E Madarász 2000 Dynamics of cell aggregation during in vitro neurogenesis by immortalized neuroectodermal progenitors. J Neurosci Res 60 184 194
30. AL Schwarzman N Singh M Tsiper L Gregori A Dranovsky MP Vitek CG Glabe PH St George-Hyslop D Goldgaber 1999 Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix. Proc Natl Acad Sci USA 96 7932 7937
31. BS Shankaranarayana Rao MK Lakshmana BL Meti TR Raju 1999 Chronic (-) deprenyl administration alters dendritic morphology of layer III pyramidal neurons in the prefrontal cortex of adult Bonnett monkeys. Brain Re 821 218 223
32. HS Shin 1997 Metabolism of selegiline in humans. Identification, excretion and stereochemistry of urine metabolites. Drug Metab Dispos 25 657 662
33. J Sivenius T Sarasoja H Aaltonen E Heinonen O Kilkku K Reinikainen 2001 Selegiline treatment facilitates recovery after stroke. Neurorehabil Neural Repair 15 183 190
34. MG Spillantini RA Crowther R Jakes M Hasegawa M Goedert 1998 alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95 6469 6473
35. B Szende J Bökönyi J Bocsi Gy Kéri F Timár K Magyar 2001 Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites. J Neural Transm 108 25 33
36. T Tábi K Magyar Szöko É 2003 Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine. Electrophoresis 24 2665 2673
37. BJ Tabner S Turnbull OM El-Agnaf D Allsop 2002 Formation of hydrogen peroxide and hydroxyl radicals from A (beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radic Biol Med 32 1076 1083
38. WG Tatton WY Ju DP Holland C Tai M Kwan 1994 (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 63 1572 1575
39. WG Tatton JS Wadia WY Ju RM Chalmers-Redman NA Tatton 1996 (-)-Deprenyl reduces neuronal apoptosis and facilitates neuronal outgrowth by altering protein synthesis without inhibiting monoamine oxidase. J Neural Transm [Suppl] 48 45 59
40. WG Tatton RME Chalmers-Redman WY Ju J Waida NA Tatton 1997 Apoptosis in neurodegenerative disorders: potential for therapy by modifying gene transcription. J Neural Transm [Suppl] 49 245 268
41. WG Tatton RME Chalmers-Redman WJH Ju M Mammen GW Carlile AW Pong NA Tatton 2002 Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301 753 764
42. T Thomas C McLendon G Thomas 1998 L-deprenyl: nitric oxide production and dilation of cerebral blood vessels. Neuroreport 9 2595 2600
43. T Thomas BR Bhavnani P Thomas 2002 Inhibition of human LDL oxidation by the neuroprotective drug l-deprenyl. Neurol Res 24 169 173
44. S Thyaga Rajan J Meites SK Quadri 1995 Deprenyl reinitiates estrous cycles, reduces serum prolactin and decreases the incidence of mammary and pituitary tumors in old acyclic rats. Endocrinology 136 1103 1110
45. S Thyaga Rajan KS Madden SY Stevens DL Felten 1999 Inhibition of tumor growth by L-deprenyl involves neural-immune interactions in rats with spontaneously developing mammary tumors. Anticancer Res 19 5023 5028
46. S Thyaga Rajan KS Madden SY Stevens DL Felten 2000 Anti-tumor effect of L-deprenyl is associated with enhanced central and peripheral neurotransmission and immune reactivity in rats with carcinogen-induced mammary tumors. J Neuroimmunol 109 95 104
47. O Weinreb O Bar-Am T Amit O Chillag-Talmor MB Youdim 2004 Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members. FASEB J 18 1471 1473
48. C Wersinger D Prou P Vernier A Sidhu 2003 Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J 17 2151 2153
49. C Wersinger P Vernier A Sidhu 2004 Trypsin disrupts the trafficking of the human dopamine transporter by alpha-synuclein and its A30P mutant. Biochemistry 43 1242 1253
50. R-F Wu Y Ichikawa 1995 Inhibition of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine metabolic activity of porcine FAD-containing monooxygenase by selective monoamine oxidase-B inhibitors. FEBS Lett 358 145 148
51. PM Yip C Siu 2001 PC12 cell utilize the homophilic binding site of L1 for cell-cell adhesion but L1-αvβ3 interaction for neurite outgrowth. J Neurochem 76 1552 1564
52. MB Youdim E Heldman HB Pollard P Fleming E McHugh 1986 Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells. Neuroscience 19 1311 1318
53. M Zhao S Momma K Delfani M Carlen RM Cassidy CB Johansson H Brismar O Shupliakov J Frisen AM Janson 2003 Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci USA 100 7925 7930
54. J Zhu RJ Hamm TM Reeves JT Povlishock LL Phillips 2000 Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp Neurol 166 136 152